Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance
- 30 November 2010
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 213 (1) , 319-324
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Serum Soluble Glycoprotein 130 Concentration Is Inversely Related to Insulin Sensitivity in Women With Polycystic Ovary SyndromeDiabetes, 2010
- Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesityAtherosclerosis, 2009
- gp130 receptor ligands as potential therapeutic targets for obesityJournal of Clinical Investigation, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin ResistanceArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Weight Loss Reduces Interleukin-18 Levels in Obese WomenThe Journal of Clinical Endocrinology & Metabolism, 2002
- A new accelerometric method to assess the daily walking practiceInternational Journal of Obesity, 2002
- EFFECT OF IL-18 ON THE RELEASE OF IL-6 AND ITS SOLUBLE RECEPTORS: sIL-6RαAND sgp130 BY HUMAN NEUTROPHILSImmunological Investigations, 2002
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care, 2000
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988